Neil Gregory Almstead, Chief Technical Ops Officer at Ptc Therapeutics, sold PTCT on Jun 22, 2026
Data as of Oct 16
▼ SELL$978K12,130 shares at $80.61Neil Gregory Almstead Chief Technical Ops OfficerPTCT Ptc Therapeutics, Inc.
- Traded
- Jun 22, 2026
- Disclosed
- Jun 24, 2026
- Filed
- 2 days after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
PTCT since disclosure
−29.8%
after the sale
Similar stocks (XLV) since disclosure
+15.2%
XLV — its sector index fund
Change in closing price from Jun 24, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.
Other trades in the same filing
- ▼ SELLNeil Gregory Almstead Chief Technical Ops OfficerPTCT Ptc Therapeutics, Inc.$944Kdisclosed Jun 24 · filed 2 days after the trade